Home › NDC Lookup › RxCUI directory › RxCUI 1807896

2 ML paricalcitol 0.005 MG/ML Injection — RxCUI 1807896

RxNorm drug concept · Semantic clinical drug
RxCUI 1807896 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1807896
Official name2 ML paricalcitol 0.005 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asparicalcitol 10 MCG per 2 ML Injection; paricalcitol 10 MCG in 2 ML Injection
FDA products mapped8
Package NDCs mapped12
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Paricalcitol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats and prevents secondary hyperparathyroidism, which is high PTH caused by chronic kidney disease. It works like vitamin D to bring PTH down. Capsules and injection are used...
  • Capsules are swallowed, either daily or three times a week depending on your plan. You can take them with or without food. The injection is given during dialysis through your acces...
  • Diarrhea, nausea, vomiting, dizziness, high blood pressure and swelling are among the most common. Mention anything that bothers you or does not go away.
  • Watch for tiredness, trouble thinking clearly, poor appetite, nausea, vomiting, constipation, increased thirst or urination, and weight loss. Call your doctor if these appear or wo...
📖 Read our full Paricalcitol guide →

🕸️ Concept Web — How 2 ML paricalcitol 0.005 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML paricalcitol 0.005 MG/ML Injection RxCUI 1807896

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Paricalcitol 73710
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Paricalcitol Injection 1736918
    • Paricalcitol Injectable Product 1161356
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Paricalcitol 0.005 MG/ML 343102

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Paricalcitol 0.005 MG/ML SCDC · 343102
  • Paricalcitol Injection SCDF · 1736918
  • Paricalcitol Injectable Product SCDG · 1161356

📦 FDA Products & Package NDCs

8 products · 12 package NDCs
12 package NDCs map to RxCUI 1807896 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55150-0212-01 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-212-01) / 1 mL in 1... PARICALCITOL Eugia US LLC 2018-10-09
55150-0213-01 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-213-01) / 1 mL in 1... PARICALCITOL Eugia US LLC 2018-10-09
55150-0214-02 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-214-02) / 2 mL in 1... PARICALCITOL Eugia US LLC 2018-10-09
55150-0215-02 25 VIAL, MULTI-DOSE in 1 CARTON (55150-215-02) / 2 mL in 1... PARICALCITOL Eugia US LLC 2018-10-09
70121-1033-05 25 VIAL, SINGLE-DOSE in 1 CARTON (70121-1033-5) / 1 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
70121-1033-07 10 VIAL, SINGLE-DOSE in 1 CARTON (70121-1033-7) / 1 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
70121-1034-05 25 VIAL, SINGLE-DOSE in 1 CARTON (70121-1034-5) / 1 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
70121-1034-07 10 VIAL, SINGLE-DOSE in 1 CARTON (70121-1034-7) / 1 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
70121-1035-05 25 VIAL, SINGLE-DOSE in 1 CARTON (70121-1035-5) / 2 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
70121-1035-07 10 VIAL, SINGLE-DOSE in 1 CARTON (70121-1035-7) / 2 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
70121-1036-05 25 VIAL, MULTI-DOSE in 1 CARTON (70121-1036-5) / 2 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
70121-1036-07 10 VIAL, MULTI-DOSE in 1 CARTON (70121-1036-7) / 2 mL in 1... Paricalcitol Amneal Pharmaceuticals LLC 2017-03-09
Observed labelers: Amneal Pharmaceuticals LLC (8) · Eugia US LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.